Pharma & Biotech

MedNews is a FREE SERVICE of Medical and Pharma Insider in conjunction with BCI News Service.

To have your company news featured at Medical and Pharma Insider, please visit www.bcinewsservice.com.

View our disclaimer/disclosure

Featuring MedNews and MedTalks Videos, video conversations with management of medical, pharma, biopharma, healthcare, telemedicine, and medical device companies.

7 hours ago
5 min

Alleviant Medical raises $75 million for clinical trials of novel technology to treat heart failure

Alleviant’s mission is to bring a safe, effective no-implant treatment option to millions of patients suffering from heart failure.

May 26
4 min

HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharma to develop therapy for Parkinsons

. NurrOn is focused on the discovering and developing novel therapies for people with neurodegenerative diseases including Parkinson's...

May 19
3 min

Acurx Pharmaceuticals prices $4 million placement to advance its new class of antibiotics

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

May 12
6 min

Regentis Biomaterials to become listed on Nasdaq through a SPAC transaction

Regentis’ current efforts are focused on orthopedic treatments using its Gelrin platform based on resorbable hydrogel implants to regenerate

May 11
3 min

Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology

DehydraTECH evidenced an ability to deliver some drugs more effectively across the blood brain barrier.

May 10
4 min

Pressure BioScience’s Pressure-Based Tech Is Ready To Spur Innovation And Growth In Life Sciences

PBI's UltraShear™ Technology (UST™) platform is tailor-made to produce high-quality CBD nanoemulsions.

May 6
6 min

MultiOmic Health Closes $6.2 Million for precision medicines for metabolic syndrome conditions

The proceeds of this financing will be used to demonstrate proof-of-concept for MultiOmic’s MOHSAIC platform in diabetic kidney disease

May 5
3 min

Galmed Pharmaceuticals and OnKai partner for clinical studies in underserved communities

Through this partnership, the companies intend to facilitate faster clinical trial enrollment and provide patients with access to medicines

May 3
4 min

Plus Therapeutics and Piramal Pharma Solutions expand collaboration for clinical trials

We significantly grew our clinical trial programs for central nervous system cancers in 2022 and we expect to continue this momentum

Apr 25
2 min

ANI Pharmaceuticals obtains FDA Approval and launches its Nitrofurantoin Oral Suspension USP

ANI Pharmaceuticals (Nasdaq: ANIP) is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing,

Apr 18
4 min

Aer Therapeutics raises $36 Million to advance development of a mucolytic for lung diseases

Aer Therapeutics is a clinical stage biopharmaceutical company with a mission to develop novel treatments for mucus-associated lung diseases

Apr 14
4 min

Novo Holdings participates in $105 million funding in Alentis Therapeutics

Alentis Therapeutics is a biotechnology company that focuses on developing treatments for CLDN1+ tumors and organ fibrosis.

Apr 3
3 min

Orion is building a pharmaceutical research ecosystem using data and artificial intelligence

Artificial intelligence-guided use of data is a competitive advantage when developing new innovative medicines.

Mar 30
3 min

Viking Therapeutics prices $250 Million public common stock offering

Viking Therapeutics is a clinical-stage biopharmaceutical company that is developing novel first-in-class or best-in-class therapies

Mar 28
3 min

EpiBiologics raises $50 million for next-generation antibody-based protein degradation platform

EpiBiologics is building a next-generation protein degradation platform that targets membrane and extracellular proteins.

Mar 4
3 min

Prana Thoracic raises $3 million to advance its lung tissue excision tool for lung cancer

Prana Thoracic is developing the first minimally invasive, lung-sparing device for early intervention of suspicious pulmonary nodules.

Mar 2
6 min

Mitsubishi Tanabe Pharma America announces preliminary results from Phase 3 ALS Trial

RADICAVA is administered in 28-day cycles by IV infusion for ALS.

Feb 24
5 min

Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million

. While various psychedelics have demonstrated promise for the treatment of PTSD, Transcend focuses on a psychoactive compound that may...

Feb 22
3 min

Rare and orphan disease focused Quoin Pharmaceuticals (Nasdaq: QNRX) prices $7 million placement

Quoin Pharmaceuticals Ltd. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products

Feb 17
3 min

LifeArc Ventures participates in a $16 million financing for Maxion Therapeutics for antibody drugs

The funds will be used for the development of novel biologics targeting ion channels and G-procoupled receptors